Insight
CARES Act Small Business Loans
March.30.2020
We summarize key points of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) most relevant to tech and life sciences startups.
Search Results
Insight
Quo Vadis FTC: What Does the Commission's Complaint Against Endo Pharmaceuticals and Others Say About the Future of Post-Actavis Hatch-Waxman Litigation and Reverse Payment Settlements?
by Robert Reznick
April.07.2016
This alert, the title of which is adapted from a March 30, 2016 FTC Staff Attorney blog post, considers the FTC’s first lawsuit challenging a ...
Insight
Cephalon and Teva's $1.2 Billion Consent Order with the FTC: Is it Really a Harbinger of Things to Come?
by Robert Reznick
June.18.2015
On June 17, 2015, the U.S. District Court for the Eastern District of Pennsylvania approved a consent order (the Consent Order) between the Federal ...
Insight
Reverse Payment Settlements Now Subject to Antitrust Scrutiny, But Lower Courts Left to Fill in the Blanks
by Robert Reznick
June.18.2013
Introduction
Earlier this week in FTC v. Actavis, No. 12-416 (U.S. Jun. 17, 2013), the Supreme Court handed down its long-anticipated ruling on ...
Insight
Court Dismisses Foreign Banks from U.S. Lawsuit Alleging Complicity in Counterfeit and Illegal Online Drug Sales
by Robert Reznick
June.14.2013
The fight against sophisticated online schemes to sell counterfeit or otherwise illegal goods is being waged by increasingly focused efforts to ...
Insight
Google's $500 Million Pharmaceutical Advertising Settlement and Implications for the Rogue Pharmaceutical Ecosystem
by Robert Reznick
September.08.2011
On August 24, 2011, the Department of Justice announced that it had entered into a $500 million forfeiture settlement with Google to resolve ...
Insight
Alert: California Supreme Court Denies Pass-On Defense in Price-Fixing Cases
by Robert Reznick
July.13.2010
On July 12, 2010, the California Supreme Court issued its much-anticipated opinion in Clayworth v. Pfizer, Inc., in which the Court held that the ...